Here are seven observations:
1. Up from $4.19 billion in 2016, the market is expected to hit $5.73 billion by 2023.
2. The increasing number of sports injuries, driven by repetitive training in the United States and China, will spur market growth.
3. Growing obesity rates; an aging population; and increasing demand for minimally invasive techniques are driving market growth, as well.
4. Physicians are seeking more durable and biocompatible implant materials.
5. The arthroscopy market spans 39 countries.
6. With improved training and induction of economical products, Brazil, China and India will see greater arthroscopic product adoption through 2023.
7. The hip arthroscopy segment will see the most rapid growth during the forecast period, with a CAGR of 14.5 percent.
More articles on sports medicine:
The first throws towards innovation — UCL repair with internal brace construction developing as option for select patients
Are vision reaction times slowed following concussions? 3 thoughts
NBA, GE Healthcare call for next round of proposals on bone stress injuries; award 4 winners of last round’s awards
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
